Cargando…
Pentacycloundecane lactam vs lactone norstatine type protease HIV inhibitors: binding energy calculations and DFT study
BACKGROUND: Novel pentacycloundecane (PCU)-lactone-CO-EAIS peptide inhibitors were designed, synthesized, and evaluated against wild-type C-South African (C-SA) HIV-1 protease. Three compounds are reported herein, two of which displayed IC(50) values of less than 1.00 μM. A comparative MM-PB(GB)SA b...
Autores principales: | Honarparvar, Bahareh, Pawar, Sachin A, Alves, Cláudio Nahum, Lameira, Jerônimo, Maguire, Glenn EM, Silva, José Rogério A, Govender, Thavendran, Kruger, Hendrik G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4387594/ https://www.ncbi.nlm.nih.gov/pubmed/25889635 http://dx.doi.org/10.1186/s12929-015-0115-5 |
Ejemplares similares
-
Molecular modelling studies of synthesized pentacyclo-undecane peptides as potential HIV-1 wild type C-SA protease inhibitors
por: Honarparvar, Bahareh, et al.
Publicado: (2013) -
Biocatalytic synthesis of lactones and lactams
por: Hollmann, Frank, et al.
Publicado: (2018) -
Synthesis and Biological Evaluations of NO-Donating Oxa- and Aza-Pentacycloundecane Derivatives as Potential Neuroprotective Candidates
por: Sharma, Rajan, et al.
Publicado: (2018) -
(S)-4-tert-Butyl-2-(1,2,3,4-tetrahydroisoquinolin-3-yl)-1,3-thiazole
por: Pawar, Sunayna, et al.
Publicado: (2012) -
{(1R,3S)-2-Benzyl-6,7-dimethoxy-1-phenyl-1,2,3,4-tetrahydroisoquinolin-3-yl}diphenylmethanol
por: Naicker, Tricia, et al.
Publicado: (2010)